Introduction
============

*Streptococcus* is a virulent Gram-positive bacterium causing severe infectious endophthalmitis.[@b1-opth-12-859] It is the common cause in delayed-onset bleb-related endophthalmitis and infection following intravitreal injection.[@b2-opth-12-859]--[@b5-opth-12-859] It is also a common causative organism in endogenous endophthalmitis, infections following cataract surgery, and ocular trauma.[@b1-opth-12-859],[@b6-opth-12-859]--[@b8-opth-12-859] Streptococcal endophthalmitis is usually a devastating eye disease. Despite aggressive treatment of the infection, visual outcomes are generally poor.[@b1-opth-12-859]--[@b9-opth-12-859] Kuriyan et al[@b8-opth-12-859] studied 63 cases of streptococcus endophthalmitis over an 11-year period and found that the most common clinical settings were bleb-associated (27%), after intravitreal injection (25%) and after cataract surgery (21%). All patients received intravitreal antibiotics and 22% of the patients underwent pars plana vitrectomy (PPV). Visual outcomes were generally poor with only 25% having best-corrected visual acuity (BCVA) of 20/400 or better and 25% of the patients had their eyes removed by operations, either evisceration or enucleation.[@b8-opth-12-859] Kurniawan et al[@b9-opth-12-859] studied 101 cases of streptococcus endophthalmitis over a 15-year period and found that 87.1% of the infection occurred postoperatively, and cataract surgery was the most commonly performed operation. Almost all patients had initial intravitreal antibiotics, and 30.7% of the patients underwent vitrectomy. Final vision was 20/100 or better in only 23.3%, whereas the majority of the patients had poor visual outcomes; 19.8% had no light perception, 14% had an evisceration, and 10.5% had an enucleation.[@b9-opth-12-859] This retrospective study looks at the possible predictive factors that may help ophthalmologists manage this severe intraocular infection. The study analyzes the clinical presentation, microbiological investigation to identify the causative organisms, treatment modalities, and visual outcomes after treatment of patients with culture-proven streptococcal endophthalmitis at a large referral eye center in northeastern Thailand.

Patients and methods
====================

This study followed the tenets of the Declaration of Helsinki and was approved by the Khon Kaen University Ethics Committee for Human Research. A retrospective medical chart review of all patients with culture-proven endophthalmitis caused by *Streptococcus* species at KKU Eye Center, Department of Ophthalmology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand from 2012 to 2016 was performed. Patient consent to review their medical records were not required by the Ethics Committee, and the case report forms had no linkage to the patient identities and the researchers respected the privacy of the patients. Inclusion criteria were clinical diagnosis of infectious endophthalmitis, history of prior bleb-associated infection, intraocular injection, ocular injury or intraocular surgery no longer than 6 weeks before, evidence of presumed extraocular sites of infection, medical or surgical treatment at the hospital, and follow-up period of at least 6 weeks. The patients who had a history of corneal disorders or retinal diseases, which might interfere with visual acuity, were excluded from the study. Those who had glaucoma and uncontrolled diabetes mellitus were also excluded. The collected data included age, gender, surgical methods, and BCVA at presentation and after treatment.

Microbiological investigation of vitreous fluid was done in all patients. Undiluted vitreous specimens were obtained by vitreous aspiration through a 23-gauge needle. The vitreous specimens were inoculated on blood agar, chocolate agar, MacConkey agar, and Sabouraud dextrose agar, as well as in thioglycolate broth and blood culture bottles. The causative organisms were then identified.

The medical treatment consisted of intravitreal injection of vancomycin (1 mg/0.1 mL) and ceftazidime (2.25 mg/0.1 mL). Intensive topical and systemic vancomycin and ceftazidime were also included. Surgical treatment consisted of complete PPV with intravitreal injection of vancomycin and ceftazidime after the surgery. PPV was indicated in all endophthalmitis patients with the loss of red reflex and substantial vitreous opacity on ultrasonography. In severe cases, PPV combined with silicone oil tamponade was performed depending on the decision of the surgeons. Patients with painful blind eyes were operated on by either evisceration or enucleation.

The primary outcome was possible predictive factors associated with improved visual outcome after treatment. The patients were classified as having "improved" visual outcome when their final BCVA was 1 or more Snellen acuity lines better than initial BCVA. They were classified as "not improved" when final BCVA was stable or worse than initial BCVA. The secondary outcomes were types of infectious endophthalmitis, causative organisms, types of treatment modalities, and rate of eye removal either by evisceration or enucleation.

Statistical analysis was performed using STATA version 10.0 (StataCorp, College Station, TX, USA). The categorical data such as gender, affected eyes, underlying diseases, types of endophthalmitis, treatment procedures, time to surgery, and visual outcomes are shown in numbers and percentages. The numerical data such as numbers of positive cultures and causative organisms are also reported in numbers and percentages. Age is denoted as mean ± standard deviation and range. Visual outcome after treatment in different patient groups was compared and analyzed using *χ*^2^ test and Fisher's exact test. The difference was considered significant when *P*-value was \<0.05.

Results
=======

Among 411 patients (417 eyes) diagnosed with infectious endophthalmitis during the 6-year study period, 45 (10.95%) patients (45 eyes) were culture positive for *Streptococcus* spp.; 24 (53.33%) males and 21 (46.67%) females. Twenty-four (53.33%) right eyes and 21 (46.67%) left eyes were affected. The mean age of the patients was 55.2±21.3; range 5--89 years. Nine (20%) patients had a history of diabetes mellitus and 10 (22.22%) patients had a history of hypertension. The types of endophthalmitis seen in this study are demonstrated in [Table 1](#t1-opth-12-859){ref-type="table"}. Sixteen patients (35.56%) developed endophthalmitis following intraocular surgery, whereas 9 patients (20%) had infection after ocular trauma. Among the other causes, endogenous endophthalmitis was found in 7 patients (15.56%), keratitis-associated disease in 2 patients (4.44%), and bleb-related infection in 1 patient (2.22%). Of 16 postoperative endophthalmitis cases, 13 developed after phacoemulsification, 2 after extraocular cataract extraction, and 1 after combined penetrating keratoplasty with cataract surgery. All 9 patients with posttraumatic endophthalmitis developed infection after penetrating ocular injuries from twigs (4) and nails (4) and by bird pecking (1).

Visual acuity at presentation is demonstrated in [Table 2](#t2-opth-12-859){ref-type="table"}. Most patients (95.56%) presented with hand motion (55.56%), light perception (28.89%), or no light perception (11.11%). There was only 1 patient who presented with counting finger and another patient who presented with visual acuity of 4/60. After treatment, most patients (53.33%) had visual acuity of no light perception. There were only 5 patients (11.1%) who achieved visual acuity of 6/60 or better. Two of these 5 patients achieved final visual acuities of 6/6.

The data on specific causative organisms are summarized in [Table 3](#t3-opth-12-859){ref-type="table"}. The 3 most common isolates were *Streptococcus pneumoniae* (44.44%), Group B β-hemolytic *Streptococcus* (26.68%), and *Streptococcus viridans* (20%). As can be seen in [Table 3](#t3-opth-12-859){ref-type="table"}, *S. pneumoniae* was the most common causative organism in the postoperative type, whereas Group B β-hemolytic *Streptococcus* was the leading cause in endogenous type. *S. viridans* was commonly identified in patients with endophthalmitis following ocular trauma and intraocular surgery.

The treatment modalities are listed in [Table 4](#t4-opth-12-859){ref-type="table"}. Most patients (62.22%) were treated by surgical interventions, either PPV with intravitreal antibiotics or PPV with intravitreal antibiotics and silicone oil tamponade. It was noted that there was a high rate of evisceration or enucleation (33.33%) in the current study.

[Table 5](#t5-opth-12-859){ref-type="table"} demonstrates the visual outcomes after treatment, and it can be seen that these improved in 9 patients (20%). There were only 5 of 9 patients who had final BCVA of 6/60 or better; most patients had poor visual outcomes ([Table 2](#t2-opth-12-859){ref-type="table"}). There were 24 patients (53.33%) who had no light perception, and 15 of 24 patients underwent eye removal, either by evisceration or enucleation ([Table 4](#t4-opth-12-859){ref-type="table"}).

Factors associated with improved visual outcome are also demonstrated in [Table 5](#t5-opth-12-859){ref-type="table"}. It was noted that posttraumatic endophthalmitis had slightly more improved visual outcomes than other types, but the difference was not statistically significant (*P*=0.65). For causative organisms, although endophthalmitis caused by *S. pneumoniae* seemed to have the most unfavorable visual outcomes when compared to those infected with other *Streptococcus* spp., there was no statistically significant difference (*P*=0.247). Regarding treatment modalities, medical treatment and PPV with antibiotics demonstrated more improved visual outcomes than PPV with antibiotics and silicone oil tamponade, but the difference was not statistically significant (*P*=0.072). For time to surgery, patients who underwent early vitrectomy (\<3 days) had more improved visual outcomes than those who underwent delayed surgery, and the difference was statistically significant (*P*\<0.001). All 6 patients in the early vitrectomy group demonstrated improved visual outcomes, and 5 of these 6 patients had final BCVA of 6/60 or better.

Discussion
==========

In the present study, streptococcal endophthalmitis accounted for 10.95% of patients with infectious endophthalmitis. This is similar to the study of Kurniawan et al[@b9-opth-12-859] that reported a rate of streptococcal endophthalmitis of 11.8%. The condition is often associated with poor visual prognosis. Only 9 patients (20%) in this study had improved vision after treatment. This finding agrees with other previous studies.[@b1-opth-12-859]--[@b9-opth-12-859] The 3 most common isolates in this study were *S. pneumoniae* (44.44%), Group B β-hemolytic *Streptococcus* (26.68%), and *S. viridans* (20%). Kuriyan et al[@b8-opth-12-859] also reported these 3 common isolates as causative organisms in their study, but with a different percentage, that is, *S. viridans* (71%), *S. pneumonia*e (21%), and Group B β-hemolytic *Streptococcus* (8%). These 3 common organisms are all normal flora in the conjunctiva that can be a source of endophthalmitis after intraocular surgery, intraocular injection, or ocular trauma.[@b10-opth-12-859] However, they were much less common than coagulase-negative *Staphylococcus*, which was the most common flora in the conjunctiva.[@b10-opth-12-859]

In this study, the most common type of endophthalmitis was the postoperative type. Most patients (35.56%) developed infection following intraocular surgery, and *S. pneumoniae* (11/16, 68.75%) was the main causative organism identified in this type. This finding is similar to the results of some previous studies,[@b9-opth-12-859],[@b11-opth-12-859],[@b12-opth-12-859] but different from the study of Kuriyan et al[@b8-opth-12-859] which reported bleb-associated infection as the most common type. Posttraumatic endophthalmitis was the next most common type (20%) in the current study, and the 2 main isolates were *S. viridans* (5/9, 55.56%) and *S. pneumoniae* (4/9, 44.44%). In addition, there were 2 eyes that developed mixed infection with *S. viridans* following ocular injuries and had final BCVA of no light perception. These findings were however not consistent with other previous studies which reported that endophthalmitis following ocular trauma was much less common.[@b8-opth-12-859],[@b10-opth-12-859]

In the present study, group B *Streptococcus* was the main organism found in endogenous endophthalmitis (6/7, 85.71%). This also agrees with other previous studies.[@b7-opth-12-859],[@b13-opth-12-859] Three of these 6 patients developed endophthalmitis after the onset of septic arthritis. Palmar abscess, cellulitis in the right foot, and liver abscess were extraocular sites of infection in 3 other patients. Among the 3 patients with septic arthritis, 2 patients was culture positive for Group B β-hemolytic *Streptococcus* and 1 patient was culture positive for Group B β-nonhemolytic *Streptococcus*. Three other patients were also positive for Group B β-hemolytic *Streptococcus*. Only 2 of 6 patients had improved visual outcome, whereas 4 of 6 patients had worse final vision and 2 of 4 patients underwent eye removal, 1 by enucleation and another by evisceration. These results were in agreement with previous studies which showed that despite intravitreal antibiotics and vitrectomy, the visual prognosis in patients with group B Streptococcus endogenous endophthalmitis is generally poor.[@b7-opth-12-859]--[@b9-opth-12-859],[@b13-opth-12-859]

PPV and intravitreal antibiotics, either with or without silicone oil tamponade, were the main treatment modalities used in this study. Silicone oil has antimicrobial properties, can prevent bacterial penetration, has compartmentalization effect to make intravitreal antibiotic concentration higher than usual (PPV without silicone oil), and can prevent post-operative retinal detachment.[@b14-opth-12-859],[@b15-opth-12-859] Previous studies also showed the benefit of vitrectomy with silicone oil tamponade over vitrectomy alone in the case of severe endophthalmitis.[@b16-opth-12-859]--[@b19-opth-12-859] However, visual outcome in this study was improved in only 8 of 28 eyes (28.57%). Although medical treatment and PPV with antibiotics ([Table 5](#t5-opth-12-859){ref-type="table"}) had more improved visual outcomes than PPV with antibiotics and silicone oil tamponade, this actually could not be compared because of the difference in severity of endophthalmitis. Medical treatment was generally used in patients with a mild degree of infection, whereas silicone oil was used in severe and complicated cases. Moreover, evisceration and enucleation were done in 33.33% of patients with streptococcal endophthalmitis. This high rate of eye removal was similar to other previous studies that reported a range of eye removal from 24.7% to 30.5%.[@b8-opth-12-859],[@b9-opth-12-859],[@b12-opth-12-859] Although these findings indicated that patients with streptococcal endophthalmitis had poor visual outcomes, it was demonstrated in this study that patients who underwent early vitrectomy \<3 days showed the most favorable visual outcomes when compared to those who underwent delayed surgery. Kurniawan et al,[@b9-opth-12-859] however, reported that early vitrectomy within 48 hours of presentation had no correlation with visual outcome. This discrepancy may be attributed to different methods of analysis. This study compared the number of patients with improved visual outcomes between early and delayed vitrectomy, whereas Kurniawan et al[@b9-opth-12-859] compared the number of patients with poor final vision (visual acuity of 6/60 or worse) between patients who had undergone vitrectomy within 48 hours and those with delayed vitrectomy. Also, this study used improved visual outcomes, which indicated that final vision gained 1 or more line of Snellen acuity compared with initial vision, whereas Kurniawan et al[@b9-opth-12-859] used only final visual acuity, which was not related to visual acuity at presentation.

Conclusion
==========

This study confirms the results of other previous studies that streptococcal endophthalmitis is a devastating eye disease and is often associated with poor visual prognosis. Only 9 patients (20%) in this study showed improved visual outcomes after treatment, and rate of eye removal was high. Early vitrectomy, done within 3 days, was associated with the most favorable visual outcomes. Early diagnosis and early vitrectomy are therefore recommended. Rapid microbiological investigation such as polymerase chain reaction can help ophthalmologists identify causative organisms early and make earlier treatment decisions, as well as advise the patients on their visual prognosis.

The strength of this study is that all patients in the study had infectious endophthalmitis with culture-proven *Streptococcus* spp.. An obvious limitation is that it is a retrospective study. There might be some important data missing. Another limitation is that the number of patients in each subgroup might be too small to observe statistically significant differences and conclusions. This study however gives some interesting information for further study in the future. It is recommended that further prospective studies with larger sample sizes be pursued.
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###### 

Types of endophthalmitis

  Types of endophthalmitis   Number   Percentage
  -------------------------- -------- ------------
  Postoperative              16       35.56
  Posttraumatic              9        20.00
  Endogenous                 7        15.56
  Keratitis-associated       2        4.44
  Bleb-related               1        2.22
  Undetermined               10       22.22
  Total                      45       100

###### 

BCVA at presentation and after treatment

  Visual acuity         At presentation, n (%)   After treatment, n (%)
  --------------------- ------------------------ ------------------------
  No light perception   5 (11.11)                24 (53.33)
  Light perception      13 (28.89)               5 (11.11)
  Hand motion           25 (55.56)               8 (17.78)
  Counting finger       1 (2.22)                 2 (4.44)
  2/60                  --                       1 (2.22)
  4/60                  1 (2.22)                 --
  6/60                  --                       1 (2.22)
  6/24                  --                       1 (2.22)
  6/12                  --                       1 (2.22)
  6/6                   --                       2 (4.44)
  Total                 45 (100)                 45 (100)

**Abbreviation:** BCVA, best-corrected visual acuity.

###### 

Causative microorganisms evidenced by culture

  Organisms                        Postoperative   Post trauma   Endogenous   Post keratitis   Bleb-related   Undetermined   N (%)
  -------------------------------- --------------- ------------- ------------ ---------------- -------------- -------------- ------------
  *Streptococcus pneumoniae*       11              4             --           2                --             3              20 (44.44)
  Group B β-hemolytic              1               --            5            --               --             6              12 (26.68)
  *Streptococcus*                                                                                                            
  *Streptococcus viridians*        4               5             --           --               --             --             9 (20.00)
  *Streptococcus suis*             --              --            1            --               --             1              2 (4.44)
  β-nonhemolytic *Streptococcus*   --              --            1            --               --             --             1 (2.22)
  *Streptococcus* spp.             --              --            --           --               1              --             1 (2.22)
  Total                            16              9             7            2                1              10             45 (100)

###### 

Treatment modalities

  Treatment modalities                    Number   Percentage
  --------------------------------------- -------- ------------
  Medical treatment                       2        4.44
  PPV with antibiotics                    16       35.56
  PPV with antibiotics and silicone oil   12       26.67
  Evisceration or enucleation             15       33.33
  Total                                   45       100

**Abbreviation:** PPV, pars plana vitrectomy.

###### 

Factors associated with improved visual outcome

  Factors                                  Improved, n (%)   Not improved, n (%)   *P*-value
  ---------------------------------------- ----------------- --------------------- -----------
  Type of endophthalmitis                                                          0.65
   Posttraumatic                           3 (33.33)         6 (66.67)             
   Endogenous                              2 (28.57)         5 (71.43)             
   Postoperative                           2 (12.5)          14 (87.5)             
   Keratitis associated                    0                 2 (100)               
   Bleb-related                            0                 1 (100)               
   Undetermined                            2 (20)            8 (80)                
  Causative organisms                                                              0.247
   β-nonhemolytic                          1 (100)           0                     
  * Streptococcus*                                                                 
  * Streptococcus suis*                    1 (50)            1 (50)                
  * Streptococcus viridans*                2 (25)            6 (75)                
   Group B β-hemolytic                     2 (16.67)         10 (83.33)            
  * Streptococcus*                                                                 
  * Streptococcus pneumonia*               3 (15)            17 (85)               
  Treatment modalities                                                             0.072
   Medical                                 1 (50)            1 (50)                
   PPV with antibiotics                    7 (43.75)         9 (56.25)             
   PPV with antibiotics and silicone oil   1 (8.33)          11 (91.67)            
  Time to surgery                                                                  \<0.001
   0--3 days                               6 (100)           0                     
   More than 3 days                        3 (13.04)         20 (86.96)            

**Abbreviation:** PPV, pars plana vitrectomy.
